Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector

Department of Gastroenterological Surgery, Transplant, and Surgical Oncology, Graduate School of Medicine and Dentistry, Okayama University, Okayama, Japan.
Biochemical and Biophysical Research Communications (Impact Factor: 2.28). 10/2005; 334(4):1121-6. DOI: 10.1016/j.bbrc.2005.06.204
Source: PubMed

ABSTRACT To enter the realm of human gene therapy, a novel drug delivery system is required for efficient delivery of small molecules with high safety for clinical usage. We have developed a unique vector "HVJ-E (hemagglutinating virus of Japan-envelope)" that can rapidly transfer plasmid DNA, oligonucleotide, and protein into cells by cell-fusion. In this study, we associated HVJ-E with magnetic nanoparticles, which can potentially enhance its transfection efficiency in the presence of a magnetic force. Magnetic nanoparticles, such as maghemite, with an average size of 29 nm, can be regulated by a magnetic force and basically consist of oxidized Fe which is commonly used as a supplement for the treatment of anemia. A mixture of magnetite particles with protamine sulfate, which gives a cationic surface charge on the maghemite particles, significantly enhanced the transfection efficiency in an in vitro cell culture system based on HVJ-E technology, resulting in a reduction in the required titer of HVJ. Addition of magnetic nanoparticles would enhance the association of HVJ-E with the cell membrane with a magnetic force. However, maghemite particles surface-coated with heparin, but not protamine sulfate, enhanced the transfection efficiency in the analysis of direct injection into the mouse liver in an in vivo model. The size and surface chemistry of magnetic particles could be tailored accordingly to meet specific demands of physical and biological characteristics. Overall, magnetic nanoparticles with different surface modifications can enhance HVJ-E-based gene transfer by modification of the size or charge, which could potentially help to overcome fundamental limitations to gene therapy in vivo.


Available from: Ryuichi Morishita, May 26, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nonviral vectors used as a carrier of plasmid DNAs in gene transfer have a problem that their transfer efficiency is low, in spite of their high safety. Magnetically enhanced transfection (hereafter called “magnetofection”) is the gene transfer method using ferromagnetic nanoparticles as nonviral vectors. In magnetofection, the contact probability of plasmid DNAs to the cell is improved by the application of a magnetic field, which will largely affect the transfer efficiency. If the carrier diffusion from the target site can be controlled, gene transfer with more safety and higher efficiency will be realized. We investigated the optimum magnetic field for magnetofection. Ferromagnetic nanoparticles coated with polyethylene imine (100 nm in diameter) were used as plasmid DNAs carrier and were confirmed to be positively charged in pH value of 7.4. Plasmid DNAs were conjugated with ferromagnetic particles by the electrostatic interaction. The transfer efficiency using these complexes was evaluated by the expression of the luciferase reporter gene with COS-7 cells, varying the distance from the surface of the high temperature superconducting (HTS) bulk magnet. In addition, diffusion suppression by applying the magnetic field was investigated in vivo experiment. As a result, transfer efficiency was strongly correlated with the magnetic field strength.
    IEEE Transactions on Applied Superconductivity 06/2014; 24(3):1-5. DOI:10.1109/TASC.2014.2298051 · 1.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Magnetic iron oxide nanoparticles have become the main candidates for biomedical and biological applications, and the application of small iron oxide nanoparticles in in vitro diagnostics has been practiced for about half a century. Magnetic nanoparticles (MNPs), in combination with an external magnetic field and/or magnetizable grafts, allow the delivery of particles to the chosen target area, fix them at the local site while the medication is released, and act locally. In this review, we focus mostly on the potential use of MNPs for biomedical and biotechnological applications, and the improvements made in using these nanoparticles (NPs) in biological applications.
    01/2015; DOI:10.3109/21691401.2014.998832
  • [Show abstract] [Hide abstract]
    ABSTRACT: Herein, we report an easy and ingenious method to functionalize magnetic iron oxide nanoparticles (MNPs) with plasmid DNA (pDNA) to obtain nanohybrid systems suitable for nucleic acid therapy. The nanohybrids were prepared by combining complexes of dendrimers and pDNA (dendriplexes) and poly(styrene) sulfonate-coated MNPs through electrostatic interactions. The effects of the dendrimer generation (generations 2, 4 and 6) and the amine to phosphate group (N/P) ratio on the hydrodynamic diameter, zeta potential, cell viability, cellular internalization and transfection efficiency of the nanohybrids were systematically investigated at different transfection conditions (including incubation time, pDNA concentration, presence or absence of an external magnetic field, and presence or absence of fetal bovine serum). The results confirmed that the nanohybrids were able to transfect NIH 3T3 cells, and that the level of gene expression (the luciferase protein reporter gene was used) was strongly dependent on the dendrimer generation, the N/P ratio, and the pDNA concentration. The best system was based on dendriplex-coated MNPs formed by generation 6 dendrimers at an N/P ratio of 10 that, at optimized conditions, led to a gene expression level which was not significantly different from that obtained only using dendriplexes. In summary, a coherent set of results was reached indicating the potential of the developed nanohybrids as effective gene delivery nanomaterials.
    Journal of Biomedical Nanotechnology 08/2015; 11(8). DOI:10.1166/jbn.2015.2101 · 7.58 Impact Factor